MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study

Christopher D. Barrett(Boston University), Michael B. Yaffe(Beth Israel Deaconess Medical Center), Rashi Jhunjhunwala(Beth Israel Deaconess Medical Center), Angela Sauaia(Statistical Service), M Yacoub(Northwell Health), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center), Peter K. Moore(University of Colorado Denver), Hunter B. Moore(Porter Adventist Hospital), Franklin L. Wright(University of Colorado Denver), Negin Hajizadeh(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Natalie Rajcooar(Northwell Health), S. Orfanos(Rutgers, The State University of New Jersey), Cory Nonnemacher(Children's Mercy Hospital), D. Benjamin Christie(University of Georgia), Robert C. McIntyre(University of Pittsburgh), Ernest E. Moore(Denver Health Medical Center), Andrew Moraco(Tufts University), Ramona Ramdeo(Northwell Health), Ammar Al‐Shammaa(Beth Israel Deaconess Medical Center), Laith Hattar(Tufts University), Lorenzo Anez‐Bustillos(Beth Israel Deaconess Medical Center), Janice Wang(Northwell Health), Ana María Agudelo Guevara(Northwell Health), Daniel Talmor(Harvard University), Hannah M. Nemec(Mercer University), Aileen Espinal(Northwell Health), Todd M. Bull(University of Colorado Denver), Elias Baedorf-Kassis(Beth Israel Deaconess Medical Center), Sabiha Hussain(Rutgers, The State University of New Jersey), Shahzad Shaefi(Beth Israel Deaconess Medical Center), Krystal Capers(Beth Israel Deaconess Medical Center), John T. Buchanan(Bouty (Italy))
Research and Practice in Thrombosis and Haemostasis
February 1, 2022
Cited by 9


Related Papers